GILD

NASDAQ

Gilead Sciences, Inc. · Healthcare · Biotechnology

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$167.56B

PE Ratio

19.2914

EV to Ebitda

12.2431

Earnings Yield

5.18%

Revenue (TTM)

$29.45B

Net Income (TTM)

$8.51B

Revenue (Annual YoY Growth)

2.51%

Revenue (Quarterly YoY Growth)

5.21%

Profit Margin

28.90%

Return on Equity

41.72%

Debt to Equity Ratio

1.125

Dividend Yield

2.39%

All fundamentals

Core10 fields›

Market Cap$167.56B

Revenue TTM$29.45B

Shares Outstanding1.24B

Float1245756698

Float Short1.83%

Days To Cover3.9044282353

Short Interest22713025.0

Insider Ownership1.03%

Relative Strength50.2

GARP404

Growth Estimates19 fields›

Revenue Growth (Annual)2.51%

Revenue Growth (Quarterly YoY)5.21%

Operating Revenue Growth (Annual)0.051747

Operating Revenue Growth (Quarterly YoY)0.016236

3-Year Revenue Growth2.83%

5-Year Revenue Growth3.63%

EPS Growth (Annual)1672.78%

EPS Growth (Quarterly YoY)23.02%

3-Year EPS Growth Rate23.06%

5-Year EPS Growth Rate133.64%

LT EPS Growth Estimates14.22%

EBITDA Growth (Annual)8.60%

EBITDA Growth (Quarterly YoY)14.30%

CFO Growth (Annual)-7.47%

CFO Growth (Quarterly YoY)11.83%

FCF Growth (Annual)-8.24%

FCF Growth (Quarterly YoY)10.40%

Dividend Growth (Annual)2.60%

Dividend Growth (Quarterly YoY)2.60%

Operations28 fields›

Revenue TTM$29.45B

Gross Margin TTM78.85%

Gross Margin (Quarterly)79.65%

R&D % of Revenue TTM19.32%

R&D Expenses TTM$5.69B

Operating Margin TTM40.15%

Operating Margin (Quarterly)37.64%

Operating Expenses TTM$11.40B

Profit Margin TTM28.90%

Profit Margin (Quarterly)27.44%

Net Income TTM$8.51B

EPS TTM6.7823

EPS (Quarterly)1.7422

EBIT Margin TTM40.15%

EBIT Margin (Quarterly)37.64%

EBITDA Margin TTM49.45%

EBITDA Margin (Quarterly)46.01%

EBITDA TTM$14.56B

CFO % of Revenue TTM34.02%

CFO % of Revenue (Quarterly)41.82%

CFO TTM$10.02B

Cash Margin25.69%

Capex % of Revenue TTM1.91%

Capital Expenditures$563.0M

FCF % of Revenue TTM32.11%

FCF % of Revenue (Quarterly)39.25%

FCF TTM$9.46B

Fundamental Score9

Efficiency6 fields›

ROE41.72%

ROA14.74%

ROIC18.52%

CROCI20.58%

Stock Comp % (Quarterly)2.89%

Stock Comp % TTM3.04%

Valuation21 fields›

P/E (TTM)19.2914

P/E Forward15.3014

P/E Ex-Cash18.1497

P/S Forward5.3758

PEG0.011

PEG Forward0.5862

P/CFO16.3925

P/FCF17.3685

EV/EBITDA (TTM)12.2431

EV/EBITDA Forward10.8624

EV/Revenues (TTM)6.0538

EV/Revenues Forward5.9002

EV/CFO16.7806

EV/FCF (TTM)18.8527

Price To Book7.1544

Price to Tangible Book-4.2782

Earnings Yield5.18%

FCF Yield5.76%

Dividend Yield2.39%

Payout Ratio45.34%

Value Score7

Relative to Industry11 fields›

Relative Gross Margin (Quarterly)1.1199

Relative Profit Margin (Quarterly)2.0849

Relative P/E0.7854

Relative P/S1.1848

Relative P/B1.1312

Relative Earnings Yield1.2732

Relative Dividend Yield0.7084

Relative ROE1.4114

Relative ROA1.5273

Relative ROIC1.2581

Relative Debt to Equity1.1389

Liquidity15 fields›

Cash Per Share7.7462

Current Ratio1.5527

Cash & ST Assets$9.61B

Total Debt$25.44B

Goodwill & Intangibles$25.29B

Total Assets$59.02B

Total Liabilities$36.40B

Shareholders Equity$22.70B

Debt to Equity1.125

Debt to Assets43.27%

Interest Expense$1.02B

Times Interest Earned11.5337

CFO to Debt (TTM)0.3923

Debt to EBITDA (TTM)1.754

Goodwill % of Assets42.85%

Yields5 fields›

Dividend Yield2.39%

Payout Ratio45.34%

Earnings Yield5.18%

Buyback Yield0.93%

Shareholder Yield3.27%

Options Flow8 fields›

Call Volume4416

Put Volume1760

Put/Call Ratio0.39855072463768115

Call $ Volume848723

Put $ Volume417116

Put/Call $ Ratio0.49146305685129305

Call OI121003

Put OI61774